ArticleCell death discovery2026

SMARCA4 activation engages FOSL1 to drive enhancer reprogramming and tumorigenic phenotypes in SMARCA4-deficient LUAD cells.

Hye-Ju Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.